Pre-operative; number of patients = 324 | |
---|---|
Age (years) | 66.5 (56–74) |
Weight (kg) | 69 (60–82) |
Haemoglobin (g/l) | 122 (109–134) |
Albumin (g/l) | 42 (40–44) |
Tumour type, n (%) | |
Ovarian | 244 (75.30%) |
Benign | 31 |
Borderline | 6 |
Malignant | 207 |
Endometrial/uterine | 62 (10%) |
Cervix | 2 (0.61%) |
Vulva | 2 (0.61%) |
Vagina | 1 (0.31%) |
Bowel | 6 (1.85%) |
Other (GI/breast) | 4 (1.23%) |
Unknown primary | 3 (0.93%) |
P-POSSUM predicted risk of mortality (%) | 5.8 (1.7–16.9) |
P-POSSUM predicted risk of morbidity (%) | 74.1 (38.5–92.5) |
Neoadjuvant chemotherapy, n (%) | 126 (39%) |